Theresa Comiskey Olsen
Directeur/Bestuurslid bij GABATHER AB
Profiel
Theresa Comiskey Olsen is currently the Chairman at Farma Investment AS, a Director at Jotunfjell AS, a Director at Aptahem AB, a Director at Ff Bygg Og Vedlikehold AS, a Director at Melius Pharma AB, a Director at Gabather AB (starting in 2023), and a Partner at Nova Law Firm.
Previously, she served as the Chairman at Mylifeproducts AS, a Director at Aqua Bio Technology ASA (from 2011 to 2012), a Director at PCI Biotech Holding ASA, a Director at AspenTech Norway AS, a Director at Medsafe ASA, a Director at NattoPharma ASA, a Director at Bio Medisinsk Innovasjon AS, a Director at Serodus ASA, a Director at Calpro AS, a Director at Calpro Diagnostics, Inc., the Managing Director at Magnus Innovasjon AS, an Independent Director at Nordic Nanovector ASA, a Director at Cyxone AB, a Director at Biovotec A, and the Secretary & General Counsel at Nycomed ASA (from 1990 to 2007).
She also worked as a Partner at Langseth Advokatfirma DA and as a Partner & Owner at Advokatfirmaet Nova Da.
Ms. Olsen obtained an undergraduate degree from the University of Pennsylvania and graduate degrees from the University of Detroit Mercy and the University of Detroit Mercy School of Law.
Actieve functies van Theresa Comiskey Olsen
| Bedrijven | Functie | Begin |
|---|---|---|
| GABATHER AB | Directeur/Bestuurslid | 30-06-2023 |
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Directeur/Bestuurslid | - |
Farma Investment AS
 Farma Investment AS Real Estate Investment TrustsFinance Farma Investment AS invests in shares and real properties. The company was founded on June 23, 2011 and is headquartered in Oslo, Norway. | Voorzitter | 22-12-2020 |
| Nova Law Firm | Corporate Officer/Principal | - |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Directeur/Bestuurslid | 25-09-2020 |
| Ff Bygg Og Vedlikehold AS | Directeur/Bestuurslid | - |
| Jotunfjell AS | Directeur/Bestuurslid | - |
Eerdere bekende functies van Theresa Comiskey Olsen
| Bedrijven | Functie | Einde |
|---|---|---|
| AQUA BIO TECHNOLOGY ASA | Directeur/Bestuurslid | 14-06-2012 |
| Nycomed ASA | Algemeen Adviseur | 01-01-2007 |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Opleiding van Theresa Comiskey Olsen
| University of Detroit Mercy | Graduate Degree |
| University of Pennsylvania | Undergraduate Degree |
| University of Detroit Mercy School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| PCI BIOTECH HOLDING ASA | Health Technology |
| AQUA BIO TECHNOLOGY ASA | Process Industries |
| CYXONE AB | Health Technology |
 | Health Technology |
| GABATHER AB | Health Technology |
| Bedrijven in privébezit | 19 |
|---|---|
NattoPharma ASA
 NattoPharma ASA Pharmaceuticals: MajorHealth Technology NattoPharma ASA engages in the manufacture and sale of nutritional and pharmaceutical products. It offers vitamin K2 under the product brand MenaQ7. The company was founded by Frode Marc Bohan on November 4, 2004 and is headquartered in Oslo, Norway. | Health Technology |
AspenTech Norway AS
 AspenTech Norway AS Packaged SoftwareTechnology Services AspenTech Norway AS engages developing industrial analytics solutions for optimizing product development and manufacturing processes by leveraging advanced sensor analysis. The firm’s products include unscramble analytics suite, unscramble, unscramble HIS, process pulse and training. It also offers solutions like batch monitoring, blend monitoring, continuous manufacturing, continuous feed monitoring (PIONA), drying optimization, fermentation monitoring, machine vision, quality and reaction monitoring. The company was founded on July 18, 1984 and is headquartered in Oslo, Norway. | Technology Services |
| Nycomed ASA | Health Technology |
Medsafe ASA
 Medsafe ASA Medical SpecialtiesHealth Technology Medsafe ASA manufactures medical equipment. The company is based in Oslo, Norway. | Health Technology |
Calpro AS
 Calpro AS Miscellaneous Commercial ServicesCommercial Services Calpro AS is a Norwegian bio-tech company that specializes in researching and developing Calprotectin based diagnostic tests. The private company is based in Lysaker, Norway. The company's solutions include a comprehensive range of individual tests and test panels, as well as support for therapeutic drug monitoring. | Commercial Services |
| Calpro Diagnostics, Inc. | |
| Jotunfjell AS | |
| Magnus Innovasjon AS | |
Serodus ASA
 Serodus ASA BiotechnologyHealth Technology Serodus ASA is a bio-medical company, which engages in the development of medicines for the treatment of diabetes related complications. It focuses on diabetic kidney disease, diabetic retinopathy, type 1 diabetes, and diabetic foot ulcers. The company was founded by Finn Olav Levy on January 21, 2008 and is headquartered in Oslo, Norway. | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Biovotec A/S | |
| Ff Bygg Og Vedlikehold AS | |
Langseth Advokatfirma DA
 Langseth Advokatfirma DA Miscellaneous Commercial ServicesCommercial Services Langseth Advokatfirma Da is a law firm based in Oslo that offers legal advice and procedure assistance to private individuals and companies. The firm has a team of talented lawyers with extensive experience in dispute resolution, including in court if necessary. One of the main focus areas of the firm is cabin and leisure adjustments, in addition to common legal issues related to real estate. The subject group is led by lawyers with extensive experience in this area. | Commercial Services |
Bio Medisinsk Innovasjon AS
 Bio Medisinsk Innovasjon AS BiotechnologyHealth Technology Bio-Medisinsk Innovasjon AS engages in the development of biotechnology, bio-medical and pharmaceutical businesses. The firm acts as an investor and incubator for start-ups. The company was founded in 2004 and is headquartered in Oslo, Norway. | Health Technology |
| Nova Law Firm | |
Farma Investment AS
Farma Investment AS Real Estate Investment TrustsFinance Farma Investment AS invests in shares and real properties. The company was founded on June 23, 2011 and is headquartered in Oslo, Norway. | Finance |
Advokatfirmaet Nova Da
 Advokatfirmaet Nova Da Miscellaneous Commercial ServicesCommercial Services Advokatfirmaet Nova Da is a medium-sized law firm based in Oslo, Norway with additional offices in Volda and Bodø. The firm has been providing high-quality legal assistance since 1995 and offers a free case evaluation. Nova prides itself on its innovative approach while maintaining a strong foundation of expertise and experience. | Commercial Services |
| Mylifeproducts AS | |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Health Technology |
